Page last updated: 2024-09-05

sb 203580 and troglitazone

sb 203580 has been researched along with troglitazone in 6 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(troglitazone)
Trials
(troglitazone)
Recent Studies (post-2010) (troglitazone)
3,48941,1371,857146287

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)troglitazone (IC50)
Bile salt export pumpRattus norvegicus (Norway rat)3.9
Bile salt export pumpHomo sapiens (human)5.05
Carbonic anhydrase 2Homo sapiens (human)0.97
Adenosine receptor A3Homo sapiens (human)5.208
Cytochrome P450 2C9 Homo sapiens (human)4
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)5.208
Thromboxane-A synthase Homo sapiens (human)2.966
Amine oxidase [flavin-containing] BHomo sapiens (human)2.07
Mitogen-activated protein kinase 1Homo sapiens (human)1.238
Peroxisome proliferator-activated receptor gammaHomo sapiens (human)1.03
5-hydroxytryptamine receptor 2BHomo sapiens (human)1.312
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)5.208
ATP-binding cassette sub-family C member 8Homo sapiens (human)1.285
ATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)1.285
Indoleamine 2,3-dioxygenase 2Mus musculus (house mouse)4.5

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H1
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1
Dai, J; Remick, DG; Wang, X; Zeng, X1
Blaschke, F; Bruemmer, D; Herle, AJ; Hsueh, WA; Law, RE; Yin, F1
Jung, JY; Kim, HT; Kim, YK; Kwon, CH; Park, JY; Yoo, CI1
Kim, YK; Kwon, CH; Yoon, CS1

Other Studies

6 other study(ies) available for sb 203580 and troglitazone

ArticleYear
Identifying off-target effects and hidden phenotypes of drugs in human cells.
    Nature chemical biology, 2006, Volume: 2, Issue:6

    Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship

2006
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013
Homocysteine mediated expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human monocytes.
    Circulation research, 2003, Aug-22, Volume: 93, Issue:4

    Topics: Antioxidants; Cells, Cultured; Chemokine CCL2; Chromans; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavonoids; Gene Expression Regulation; Genistein; Homocysteine; Humans; Imidazoles; Indoles; Interleukin-8; Monocytes; Naphthalenes; Onium Compounds; Pyridines; Pyrrolidines; Reactive Oxygen Species; RNA, Messenger; Sulfonamides; Thiazoles; Thiazolidinediones; Thiocarbamates; Time Factors; Troglitazone; Tyrphostins

2003
Signaling pathways involved in induction of GADD45 gene expression and apoptosis by troglitazone in human MCF-7 breast carcinoma cells.
    Oncogene, 2004, Jun-03, Volume: 23, Issue:26

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma; Cell Cycle; Chromans; Enzyme Inhibitors; Female; Flavonoids; GADD45 Proteins; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Proteins; Pyridines; RNA, Small Interfering; Signal Transduction; Thiazolidinediones; Troglitazone; Tumor Cells, Cultured

2004
Role of mitogen-activated protein kinase (MAPK) in troglitazone-induced osteoblastic cell death.
    Toxicology, 2007, May-05, Volume: 234, Issue:1-2

    Topics: 3T3 Cells; Anilides; Animals; Apoptosis; Blotting, Western; Butadienes; Caspase 3; Caspase Inhibitors; Cell Survival; Chromans; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Flow Cytometry; Hypoglycemic Agents; Imidazoles; MAP Kinase Kinase 1; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mice; Mitogen-Activated Protein Kinases; Nitriles; Osteoblasts; PPAR gamma; Pyridines; Reactive Oxygen Species; Thiazolidinediones; Troglitazone

2007
Ciglitazone induces caspase-independent apoptosis via p38-dependent AIF nuclear translocation in renal epithelial cells.
    Toxicology, 2008, Feb-03, Volume: 244, Issue:1

    Topics: Active Transport, Cell Nucleus; Animals; Apoptosis; Apoptosis Inducing Factor; Blotting, Western; Cell Line; Cell Nucleus; Cell Survival; Chromans; Clofibric Acid; Dose-Response Relationship, Drug; Epithelial Cells; Fibric Acids; Flow Cytometry; Fluorescent Antibody Technique; G1 Phase; Imidazoles; Kidney Tubules; Membrane Potential, Mitochondrial; Opossums; p38 Mitogen-Activated Protein Kinases; PPAR gamma; Pyridines; Thiazolidinediones; Troglitazone

2008